Click here for Inflectra® (infliximab) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
The Inflectra Summary of Product Characteristics (SPC) should be read and understood in full before prescribing this medicine.1
Inflectra MUST NOT be given in:
Also consider the safety and screening recommendations below for any patient diagnosed with Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and severe plaque psoriasis for whom you are considering initiating Inflectra:1
Actively screen and monitor patients for infections
Screenings for latent/active tuberculosis and hepatitis B
Bring paediatric patients up to date with all vaccinations prior to intiating treatment if possible
The general condition of patients (e.g. symptoms of bacterial or viral infections, fever, ulcers, or purulent discharge from fistulas)
Discuss potential health issues with patients
Consider the long half-life of infliximab when planning certain vaccinations or surgical procedures
Closely monitor patients who require surgery for infections
Avoid concurrent administration of Inflectra with live vaccines or therapeutic infectious agents such as live attenuated bacteria
Also avoid administration of live vaccines in infants ‚<6 months of age who have been exposed to infliximab in utero
Learn about the clinical evidence supporting the use of Inflectra in patients with rheumatoid arthritis
Learn about the dosing and administration of Inflectra in patients with rheumatoid arthritis
Find out more
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020